Skip to content

Meet us at COP31Read more

Marinomed Biotech AG Sustainability Reports

Marinomed Biotech AG is a biopharmaceutical company that develops innovative patent-protected medical products and therapeutics based on its proprietary technology platforms. The company primarily targets respiratory and immunological diseases.

Sector: Manufacturing

Country: Austria

Exchange: Vienna Stock Exchange

LEI: 529900GN3B1EN80XF405

FIGI: BBG00608FFP1

21 reports from 2018 to 2025